1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. GINO BIOW
  6. News
  7. Summary
    DNA   US37611X1000

GINO BIOW

(DNA)
Delayed Nasdaq  -  11:19 2021-10-05 am EDT
11.66 USD   +2.42%
08/15GINKGO BIOWORKS HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
08/15SOARING EAGLE ACQUISITION : Ginkgo Bioworks Reports Second Quarter 2022 Financial Results - Form 8-K
PU
08/15Ginkgo Bioworks Net Loss Widens While Sales Increase in Q2; Lifts 2022 Revenue Guidance -- Shares Jump After Hours
MT
SummaryQuotesChartsNewsRatingsCalendarCompany 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sloan, Sagansky-backed Spinning Eagle SPAC upsizes offering size to $2 bln

06/24/2021 | 03:04pm EDT

June 24 (Reuters) - Blank-check firm Spinning Eagle Acquisition Corp, backed by former Hollywood executives Harry Sloan and Jeff Sagansky, on Thursday upsized its offering to $2 billion after the Nasdaq eased the process for such companies to spin off new entities.

The exchange operator recently approved a proposal that allows special purpose acquisition companies (SPACs) to spin off new investment vehicles without additional paperwork. That would make them similar to a private equity fund and enable blank-check firms to invest in more than one company in separate transactions.

Spinning Eagle in December had filed for a $1.5 billion share sale, proposing a structure to allow it to carve out a portion of raised capital into a new shell company and pursue multiple deals.

However, the SPAC's backers held back their plan in February following feedback about the proposal from the U.S. Securities and Exchange Commission.

If priced successfully, Spinning Eagle's IPO of 200 million units for $10 each would be the biggest SPAC offer this year, even as blank-check dealmaking has slowed down significantly on tighter regulation and waning investor appetite.

Spinning Eagle said that unused proceeds from the IPO could be used to create a new and independent SPAC called SpinCo.

If Spinning Eagle chooses to do multiple deals, its structure would be similar to billionaire hedge fund investor William Ackman's Pershing Square Tontine Holdings, which was spun off into an entity called PSTH Remainco after a deal with Universal Music Group earlier this month.

SPACs are shells of cash that are publicly listed for the sole purpose of taking an unknown private target public through a merger, within two years of the listing.

Spinning Eagle's offering comes more than a month after another SPAC backed by Sloan and Sagansky agreed to take biotech firm Ginkgo public at a $17.5 billion valuation.

Goldman Sachs is the sole underwriter for Spinning Eagle's IPO. (Reporting by Niket Nishant in Bengaluru; Editing by Anirban Sen and Ramakrishnan M.)


© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
NASDAQ COMPOSITE 0.62% 13128.05 Real-time Quote.-16.60%
PERSHING SQUARE HOLDINGS, LTD. -0.30% 32.95 Real-time Quote.-19.83%
UNIVERSAL MUSIC GROUP N.V. 0.93% 21.64 Real-time Quote.-12.67%
All news about GINO BIOW
08/15GINKGO BIOWORKS HOLDINGS, INC. Management's Discussion and Analysis of Financial Condi..
AQ
08/15SOARING EAGLE ACQUISITION : Ginkgo Bioworks Reports Second Quarter 2022 Financial Results ..
PU
08/15Ginkgo Bioworks Net Loss Widens While Sales Increase in Q2; Lifts 2022 Revenue Guidance..
MT
08/15Earnings Flash (DNA) GINKGO BIOWORKS Posts Q2 Revenue $144.6M
MT
08/15Ginkgo Bioworks Reports Second Quarter 2022 Financial Results
PR
08/15Ginkgo Bioworks, XpresSpa Get Contract to Expand CDC's SARS-CoV-2 Surveillance Program ..
MT
08/15Ginkgo Bioworks and XpresCheck Receive Award to Expand CDC's Traveler-Based SARS-CoV-2 ..
AQ
08/12Rwanda, U.S. Biotech Firm in Joint Effort to Address Biosecurity Challenges
AQ
08/11SECTOR UPDATE : Health Care Stocks on Downward Slide
MT
08/11Ginkgo Bioworks, Synlogic Shares Rise Amid Joint Drug Candidate for Gout
MT
More news
Analyst Recommendations on GINO BIOW
More recommendations
Chart GINO BIOW
Duration : Period :
GINO BIOW Technical Analysis Chart | MarketScreener
Full-screen chart
Managers and Directors
Jason Kelly Co-Founder
Reshma Shetty Co-Founder
Mark Dmytruk Chief Financial Officer
Marijn E. Dekkers Chairman
Bartholomew Canton Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
GINO BIOW0.00%6 220
MODERNA, INC.-30.40%66 966
IQVIA HOLDINGS INC.-12.01%45 846
LONZA GROUP AG-25.13%44 851
SEAGEN INC.9.01%31 380
ALNYLAM PHARMACEUTICALS, INC.36.22%28 068